Spread of the coronavirus has exposed troubling problems at fur farms and how we respond to outbreaks there.
that shape citizens' preference toward COVID-19 vaccines and their time preference to be vaccinated, which is overlooked in extant literature. Results suggest people are most concerned about vaccines' efficacy and severe side-effects, and that cash incentives are not useful in enhancing vaccine ...
Currently, the CDC onlyrecommendswearing a high-quality mask or respirator if the COVID-19 hospital admission level where someone lives is in the high category and says certain high-risk groups should consider masking. Hochman said data shows masks are effective at reducing the odds of co...
The findings of the new study are important because COVID-19 vaccines for babies under six months aren't currently being developed. Pfizer and BioNTech's COVID-19 vaccine for children age 6 months through 4 years is currently being tested, after the companies and ...
Johnson & Johnson's COVID-19 vaccine may be effective against variants of the virus, according to the Food and Drug Administration.
What Is Pooled Testing for COVID-19 and How Can It Help Fight the Virus? More Reuters FILE PHOTO: Overheated, a healthcare worker takes a break as people wait in their vehicles in long lines for the coronavirus disease (COVID-19) testing in Houston, Texas, ...
What’s the Status of the COVID-19 Vaccine Mandate in the US? More The Associated Press What’s the status of the COVID-19 vaccine mandate in the US? (AP Illustration/Peter Hamlin) By TOM KRISHER, Associated Press What’s the status of the COVID-19 vaccine mandate ...
While the public has grown accustomed to calling additional shots "boosters," health officials are nowmoving away from the word "booster,"instead calling this year's shots the "2023-2024 COVID-19 vaccine" or simply the"updated COVID-19 vaccine."This clarification helps distinguish previous addit...
The Pfizer–BioNTech vaccine has passed safety and efficacy tests — but researchers still have many questions about how this and other vaccines will perform as they’re rolled out to millions of people.
A new COVID-19 strain has emerged that appears likely to stick around in the U.S. through the holiday season. SEE: Latest Coronavirus and Vaccine News JN.1, which is a close relative to BA.2.86, is the fastest growing variant in the U.S. According to estimates from the Cen...